161 related articles for article (PubMed ID: 38067223)
21. Characteristics and risk factors of instrumentation failure following total en bloc spondylectomy.
Shimizu T; Kato S; Demura S; Shinmura K; Yokogawa N; Kurokawa Y; Yoshioka K; Murakami H; Kawahara N; Tsuchiya H
Bone Joint J; 2023 Feb; 105-B(2):172-179. PubMed ID: 36722055
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
Sun B; Brooks ED; Komaki R; Liao Z; Jeter M; McAleer M; Balter PA; Welsh JD; O'Reilly M; Gomez D; Hahn SM; Sepesi B; Rice DC; Heymach JV; Chang JY
J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis.
Lee TH; Kim DY; Wu HG; Lee JH; Kim HJ
Radiat Oncol; 2021 Nov; 16(1):222. PubMed ID: 34794471
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcomes of stereotactic ablative radiation therapy for non-spinal bone metastases: focus on response assessment and treatment indication.
Yu T; Choi CW; Kim KS
Br J Radiol; 2019 Jul; 92(1099):20181048. PubMed ID: 31075040
[TBL] [Abstract][Full Text] [Related]
25. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study.
Blake-Cerda M; Lozano-Ruíz F; Maldonado-Magos F; de la Mata-Moya D; Díaz-García D; Lara-Mejía L; Zatarain-Barrón ZL; Cuevas-Góngora MF; Barron-Barron F; Corona-Cruz JF; Cabrera-Miranda L; Arroyo-Hernández M; Gerson R; Arrieta O
Lung Cancer; 2021 Feb; 152():119-126. PubMed ID: 33385737
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the prognostic factors of total en bloc spondylectomy and total piecemeal spondylectomy in patients with Enneking stage III giant cell tumor in the thoracic and lumbar spine.
Zhou H; Wu F; Dang L; Li Y; Liu X; Liu Z; Wei F
Eur Spine J; 2023 Jan; 32(1):254-260. PubMed ID: 36383243
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.
Yang JF; Lo CH; Lee MS; Lin CS; Dai YH; Shen PC; Chao HL; Huang WY
Radiat Oncol; 2019 Oct; 14(1):180. PubMed ID: 31640728
[TBL] [Abstract][Full Text] [Related]
29. More than 10-year follow-up after total en bloc spondylectomy for spinal tumors.
Kato S; Murakami H; Demura S; Yoshioka K; Kawahara N; Tomita K; Tsuchiya H
Ann Surg Oncol; 2014 Apr; 21(4):1330-6. PubMed ID: 24150193
[TBL] [Abstract][Full Text] [Related]
30. Rod fracture and related factors after total en bloc spondylectomy.
Park SJ; Lee CS; Chang BS; Kim YH; Kim H; Kim SI; Chang SY;
Spine J; 2019 Oct; 19(10):1613-1619. PubMed ID: 31059817
[TBL] [Abstract][Full Text] [Related]
31. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer.
Hannan R; Christensen M; Christie A; Garant A; Pedrosa I; Robles L; Mannala S; Wang C; Hammers H; Arafat W; Courtney K; Bowman IA; Sher D; Ahn C; Cole S; Choy H; Timmerman R; Brugarolas J
Eur Urol Oncol; 2022 Dec; 5(6):695-703. PubMed ID: 35985982
[TBL] [Abstract][Full Text] [Related]
33. The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
Franzese C; Marini B; Baldaccini D; Badalamenti M; Navarria P; Bellu L; Franceschini D; Comito T; Clerici E; Teriaca MA; Massaro M; Di Cristina L; Lo Faro L; Tomatis S; Scorsetti M
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4411-4417. PubMed ID: 36109401
[TBL] [Abstract][Full Text] [Related]
34. Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.
Benzaquen J; Bondiau PY; Otto J; Marquette CH; Berthet JP; Naghavi AO; Schiappa R; Hannoun-Levi JM; Padovani B; Doyen J
Radiat Oncol; 2023 Jun; 18(1):97. PubMed ID: 37287020
[TBL] [Abstract][Full Text] [Related]
35. Clinical and oncologic outcomes of posterior only total en bloc spondylectomy for spinal metastasis involving third lumbar vertebra: A case series.
Paholpak P; Morimoto T; Wisanuyotin T; Sirichativapee W; Sirichativapee W; Kosuwon W; Kasai Y; Murakami H
Medicine (Baltimore); 2024 Feb; 103(5):e37145. PubMed ID: 38306532
[TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes of Stereotactic Ablative Radiotherapy for All Stages of Non-Small Cell Lung Cancer; Definitive versus Consolidative.
Kim H; Kim SM; Yang DS; Lee KH; Kim YB
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143981
[No Abstract] [Full Text] [Related]
37. Total En Bloc Spondylectomy for Solitary Metastatic Tumors of the Fourth Lumbar Spine in a Posterior-Only Approach.
Huang W; Wei H; Cai W; Xu W; Yang X; Liu T; Wu Z; Huang Q; Yan W; Xiao J
World Neurosurg; 2018 Dec; 120():e8-e16. PubMed ID: 29990608
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of thoracolumbar tumors with total en bloc spondylectomy and the results of spinal stability reconstruction].
Yang Q; Li JM; Yang ZP; Li X; Li ZF; Yan J
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):225-30. PubMed ID: 23880006
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
[TBL] [Abstract][Full Text] [Related]
40. Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer.
Wijetunga NA; Dos Anjos CH; Zhi WI; Robson M; Tsai CJ; Yamada Y; Dover L; Gillespie EF; Xu AJ; Yang JT
Cancer Med; 2021 Aug; 10(15):5163-5174. PubMed ID: 34159748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
